BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38709562)

  • 21. Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways.
    Bajaj A; Ihegword A; Qiu C; Small AM; Wei WQ; Bastarache L; Feng Q; Kember RL; Risman M; Bloom RD; Birtwell DL; Williams H; Shaffer CM; Chen J; Center RG; Denny JC; Rader DJ; Stein CM; Damrauer SM; Susztak K
    Kidney Int; 2020 May; 97(5):1032-1041. PubMed ID: 32247630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
    Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
    Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of APOL1 kidney risk variants on glomerular transcriptomes.
    Kopp JB; Heymann J
    Kidney Int; 2022 Jul; 102(1):16-19. PubMed ID: 35738828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
    Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
    Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of endoplasmic reticulum stress signaling rescues cytotoxicity of human apolipoprotein-L1 risk variants in Drosophila.
    Gerstner L; Chen M; Kampf LL; Milosavljevic J; Lang K; Schneider R; Hildebrandt F; Helmstädter M; Walz G; Hermle T
    Kidney Int; 2022 Jun; 101(6):1216-1231. PubMed ID: 35120995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOL1 risk variants and the development of HIV-associated nephropathy.
    Goyal R; Singhal PC
    FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
    Kopp JB; Heymann J; Winkler CA
    Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.
    Sampson MG; Robertson CC; Martini S; Mariani LH; Lemley KV; Gillies CE; Otto EA; Kopp JB; Randolph A; Vega-Warner V; Eichinger F; Nair V; Gipson DS; Cattran DC; Johnstone DB; O'Toole JF; Bagnasco SM; Song PX; Barisoni L; Troost JP; Kretzler M; Sedor JR;
    J Am Soc Nephrol; 2016 Mar; 27(3):814-23. PubMed ID: 26150607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A focus on the association of Apol1 with kidney disease in children.
    Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
    Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.
    Madhavan SM; O'Toole JF; Konieczkowski M; Barisoni L; Thomas DB; Ganesan S; Bruggeman LA; Buck M; Sedor JR
    JCI Insight; 2017 Jul; 2(14):. PubMed ID: 28724794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
    Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
    Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
    J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Young BA; Wilson JG; Reiner A; Kestenbaum B; Franceschini N; Bansal N; Correa A; Himmelfarb J; Katz R
    Kidney Med; 2021; 3(6):962-973.e1. PubMed ID: 34939005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury.
    Andrews M; Yoshida T; Henderson CM; Pflaum H; McGregor A; Lieberman JA; de Boer IH; Vaisar T; Himmelfarb J; Kestenbaum B; Chung JY; Hewitt SM; Santo BA; Ginley B; Sarder P; Rosenberg AZ; Murakami T; Kopp JB; Kuklenyik Z; Hoofnagle AN
    PLoS One; 2022; 17(10):e0276649. PubMed ID: 36279295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
    Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
    Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Masimango MI; Jadoul M; Binns-Roemer EA; David VA; Sumaili EK; Winkler CA; Limou S
    Kidney Int Rep; 2022 Mar; 7(3):474-482. PubMed ID: 35257060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
    Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
    BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
    Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
    J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.